Mawson Infrastructure Group Inc. — Director's Dealing 2018

May 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-03-26

Reporting Person: Ridge Valley Corp (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-26	Common Stock, par value $0.001 per share	C	213524	$1.332	Acquired	1394805	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-26	2017 Future Investment Rights	$1.332	C	213524	Disposed	2017-12-31	Common Stock (13524)	Direct

Footnotes

F1: The 213,524 shares of common stock of the Issuer were issued upon the exercise of a portion of the 2017 Investment Rights (as defined below).

F2: Represents (i) 1,040,760 shares of common stock of the Issuer, (ii) 259,192 shares of common stock of the Issuer issuable upon the conversion of the Convertible Notes (as defined below) and (iii) 94,853 shares of common stock issuable upon the exercise of the 2017 Investment Rights (as defined below). Ridge Valley Corporation ("Ridge") is a Seychelles corporation. Priscilla Julie is the sole director of Ridge and holds the voting and dispositive power of the shares of common stock beneficially owned by Ridge. Noam Danenberg, the Issuer's Chief Operating Officer, is also the son-in-law of Mrs. Hanna Harpaz, who owns 49% of Ridge.

F3: Ridge's outstanding loan to the Issuer in the principal amount of $274,048, which bears interest at an annual rate of 4% (the "Convertible Notes") is currently convertible (including accrued interest as of May 1, 2018), into 259,192 shares of common stock of the Issuer based on a loan conversion price per share of $1.1112. The maturity date of the Convertible Notes is December 31, 2018. Ridge has the right (the "2017 Investment Right") until June 30, 2019, to invest up to $126,344,658, at a price per share of $1.332.